Grove Collaborative (GROV) 10-Q 10 Aug 21 2021 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 30, 2021	Aug. 10, 2021
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Entity Registrant Name	Virgin Group Acquisition Corp. II
Entity Central Index Key	0001841761
Current Fiscal Year End Date	--12-31
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-40263
Entity Address, State or Province	NY
Entity Incorporation, State or Country Code	E9
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Address, Address Line One	65 Bleecker Street, 6th Floor
Entity Address, City or Town	New York
Entity Address, Postal Zip Code	10012
City Area Code	212
Local Phone Number	497-9050
Entity Current Reporting Status	No
Entity Small Business	true
Entity Shell Company	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Class A Ordinary Shares
Document Information [Line Items]
Title of 12(b) Security	Class A ordinary share, par value $0.0001 per share
Trading Symbol	VGII
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		40,250,000
Class B Ordinary Shares
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		10,062,500
Warrant
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants, each one whole warrant exercisable for one share of Class A ordinary share at an exercise price of $11.50
Trading Symbol	VGII.W
Security Exchange Name	NYSE
Capital Units
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one share of Class A ordinary share and one-fifth of one redeemable warrant
Trading Symbol	VGII.U
Security Exchange Name	NYSE

Condensed Balance Sheet

Condensed Balance Sheet	Jun. 30, 2021USD ($)
Current Assets:
Cash	$ 118,875
Prepaid expenses	1,087,577
Total current assets	1,206,452
Cash and Investments held in Trust Account	402,515,362
TOTAL ASSETS	403,721,814
Current liabilities:
Accrued costs and expenses	53,962
Total current liabilities	53,962
Warrant liability	20,313,609
Deferred underwriters' discount	14,087,500
Total liabilities	34,455,071
Commitments and Contingencies
Ordinary shares subject to possible redemption, 36,426,674 at a redemption value of $10.00 per share	364,266,740
Shareholders' Equity:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Additional paid-in capital	5,993,201
Accumulated deficit	(994,586)
Total Shareholders' equity	5,000,003
TOTAL LIABILITIES AND SHAREHOLDER'S EQUITY	403,721,814
Common Class A
Shareholders' Equity:
Common stock value	382
Total Shareholders' equity	382
Common Class B
Shareholders' Equity:
Common stock value	1,006
Total Shareholders' equity	$ 1,006

Condensed Balance Sheet (Parent

Condensed Balance Sheet (Parenthetical)	Jun. 30, 2021$ / sharesshares
Temporary equity redemption price per share | $ / shares	$ 10
Preferred stock, par value | $ / shares	$ 0.0001
Preferred stock, shares authorized	1,000,000
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0
Common Class A
Shares subject to possible redemption	36,426,674
Temporary equity redemption price per share | $ / shares	$ 10
Common stock, par value | $ / shares	$ 0.0001
Common stock, shares authorized	200,000,000
Common stock, shares issued	3,823,326
Common stock, shares outstanding	3,823,326
Common Class B
Common stock, par value | $ / shares	$ 0.0001
Common stock, shares authorized	20,000,000
Common stock, shares issued	10,062,500
Common stock, shares outstanding	10,062,500

Condensed Statement Of Operatio

Condensed Statement Of Operations - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2021
Formation and operating costs	$ 249,630	$ 276,986
Loss from Operations	(249,630)	(276,986)
Other income (expense):
Interest income on cash and investments held in Trust Account	13,918	15,362
Offering costs allocated to warrants	(72,862)	(570,496)
Excess of Private Placement warrants over purchase price	46,327	(162,466)
Total other expense, net	(12,617)	(717,600)
Net loss	$ (262,247)	$ (994,586)
Basic and diluted weighted average shares outstanding	9,887,500	9,805,412
Basic and diluted net income or loss per share	$ (0.03)	$ (0.10)
Class A Redeemable Common Stock
Other income (expense):
Basic and diluted weighted average shares outstanding	39,550,000	39,221,649
Basic and diluted net income or loss per share	$ 0	$ 0
Common Class B
Other income (expense):
Net loss	$ 276,165	$ 1,009,948
Basic and diluted weighted average shares outstanding	9,887,500	9,805,412
Basic and diluted net income or loss per share	$ (0.03)	$ (0.10)

Condensed Statements Of Changes

Condensed Statements Of Changes In Shareholders' Equity - USD ($)	Total	Class A Ordinary Shares	Class B Ordinary Shares	Additional Paid In Capital	Accumulated Deficit
Balance Beginning at Jan. 12, 2021	$ 0	$ 0	$ 0
Balance Beginning, Shares at Jan. 12, 2021		0	0
Issuance of Class B Ordinary shares to Sponsor	25,000		$ 1,006	$ 23.994
Issuance of Class B Ordinary shares to Sponsor, Shares			10,062,500
Sale of 35,000,000 Units on March 25, 2021 through IPO less fair value of public warrants	341,223,613	$ 3,500		341,220,113
Sale of 35,000,000 Units on March 25, 2021 through IPO less fair value of public warrants, Shares		35,000,000
Offering costs	(19,347,891)			(19,347,891)
Net loss	(732,339)				$ (732,339)
Class A ordinary shares subject to possible redemption	(316,168,382)	$ (3,162)		(316,165,220)
Class A ordinary shares subject to possible redemption, Shares		(31,616,838)
Balance Ending at Mar. 31, 2021	5,000,001	$ 338	$ 1,006	5,730,996	(732,339)
Balance Ending, Shares at Mar. 31, 2021		3,383,162	10,062,500
Balance Beginning at Jan. 12, 2021	0	$ 0	$ 0
Balance Beginning, Shares at Jan. 12, 2021		0	0
Net loss	(994,586)		$ 1,009,948
Balance Ending at Jun. 30, 2021	5,000,003	$ 382	$ 1,006	5,993,201	(994,586)
Balance Ending, Shares at Jun. 30, 2021		3,823,326	10,062,500
Balance Beginning at Mar. 31, 2021	5,000,001	$ 338	$ 1,006	5,730,996	(732,339)
Balance Beginning, Shares at Mar. 31, 2021		3,383,162	10,062,500
Offering costs	(1,764,638)			(1,764,638)
Net loss	(262,247)		$ 276,165		(262,247)
Sale of 5,250,000 over-allotment Units on April 12, 2021	50,125,245	$ 525		50,124,720
Sale of 5,250,000 over-allotment Units on April 12, 2021, Shares		5,250,000
Change in Class A ordinary shares subject to possible redemption	(48,098,358)	$ (481)		(48,097,877)
Change in Class A ordinary shares subject to possible redemption, Shares		(4,809,836)
Balance Ending at Jun. 30, 2021	$ 5,000,003	$ 382	$ 1,006	$ 5,993,201	$ (994,586)
Balance Ending, Shares at Jun. 30, 2021		3,823,326	10,062,500

Condensed Statement Of Changes

Condensed Statement Of Changes In Shareholder's Equity (Parenthetical) - Class A Ordinary Shares - shares	Apr. 12, 2021	Mar. 25, 2021
Sale of Units through IPO less fair value of public warrants		35,000,000
Sale of over -allotment Units	5,250,000

Condensed Statement Of Cash Flo

Condensed Statement Of Cash Flows	6 Months Ended
	Jun. 30, 2021USD ($)
Cash flows from operating activities:
Net loss	$ (994,586)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest income on cash and investments held in Trust Account	(15,362)
Offering costs allocated to warrant liability	570,496
Change in fair value of warrant liability	162,466
Changes in operating assets and liabilities:
Prepaid assets	(1,087,577)
Accrued costs and expenses	53,962
Net cash used in operating activities	(1,310,601)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(402,500,000)
Net cash used in investing activities	(402,500,000)
Cash Flows from Financing Activities:
Proceeds from purchase of Class B shares by initial shareholder	25,000
Proceeds from initial public offering, net of underwriters' discount	394,450,000
Proceeds from private placement	10,050,000
Payment of offering costs	(595,524)
Net cash provided by financing activities	403,929,476
Net change in cash	118,875
Cash, beginning of period	0
Cash, end of the period	118,875
Supplemental disclosure of cash flow information:
Initial classification of Class A ordinary shares subject to possible redemption	316,378,064
Deferred underwriting commissions charged to additional paid in capital	14,087,500
Change in value of Class A ordinary shares subject to possible redemption	$ 47,888,678

Organization and Business Opera

Organization and Business Operations	6 Months Ended
	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Business Operations	Note 1 — Organization and Business Operations Virgin Group Acquisition Corp. II (the “Company”), was incorporated as a Cayman Islands exempted company on January 13, 2021 As of June 30, 2021, the Company had not commenced any operations. All activity for the period through June 30, 2021 relates to the Company’s formation and the initial public offering (“IPO”), which is described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating The registration statement for the Company’s IPO was declared effective on March 22, 2021 (the “Effective Date”). On March 25, 2021, the Company consummated the IPO of 35,000,000 units (the “Units”). Each unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-fifth Concurrently with the closing of the IPO, the Company completed the private sale (the “Private Placement”) of 6,000,000 warrants (the “Private Placement Warrants”) to Virgin Group Acquisition Sponsor II LLC (the “Sponsor”) at a purchase price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company of $9,000,000, which is discussed in Note 4. Transaction costs of the IPO amounted to $19,845,525 consisting of $7,000,000 of underwriting discount, $12,250,000 of deferred underwriting discount, and $595,525 of other offering costs. On April 1 3 T Additional transaction costs of the overallotment amounted to $2,887,500 consisting of $1,050,000 of underwriting discount and $1,837,500 of deferred underwriting discount. As of June 30, 2021, $118,875 of cash is not held in the Trust Account (as defined below) and is available for working capital purposes. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting commissions) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires an interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). Following the closing of the Public Offering on March 25, 2021, and the over-allotment exercise on April 13, 2021, an amount equal to at least 2a-7 pre-initial The Company will provide the holders of its issued and outstanding public shares (the “Public Shareholders”) of its Class A Ordinary Shares, sold in the IPO (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations), calculated as of two business days prior to the completion of the Business Combination. The per-share The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company If a shareholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote any Founder Shares (as defined in Note 3) and Public Shares held by it in favor of approving a Business Combination. Additionally, each public shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination. Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association will provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company. The Company’s sponsor has agreed to waive: (i) its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of the Company’s Business Combination and (ii) their redemption rights with respect to their Founder Shares and any Public Shares held by them in connection with a shareholder vote to approve an amendment to the Company’s Amended and Restated Memorandum and Articles of Association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete its Business Combination within 24 months from the closing of the Proposed Public Offering or (B) with respect to any other provision relating to shareholders’ rights or pre-initial If the Company is unable to complete its initial business combination within the Combination Period, the Company will: i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible, but not more than ten business days per-share The Company’s sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to any founder shares held by it if the Company fails to complete its initial business combination within the Combination Period. However, if the sponsor acquires public shares in or after the IPO, the sponsor will be entitled to liquidating distributions from the Trust Account with respect to such public shares if the Company fails to complete a Business Combination during the Combination Period. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 Liquidity and Capital Resources As of June 30, 2021, the Company had $118,875 in its operating bank account and working capital of approximately $1.2 million. The Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating the business. However, if the estimate of the costs of identifying a target business, undertaking in-depth Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

Significant Accounting Policies

Significant Accounting Policies	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Significant Accounting Policies	Note 2 — Significant Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The interim results for the three month period ending June 30, 2021 and for the period from January 13, 2021 (inception) through June 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s final prospectus filed by the Company with the SEC on March Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Further, Section 102(b)(1) of the JOBS non-emerging Use of Estimates The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, actual results could differ from those estimates. Estimates made in preparing these condensed financial statements include, among other things, the measurement of derivative warrant liabilities. Changes in these estimates and assumptions could have a significant impact on results in future periods. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021. Investment in Trust Account At June 30, 2021, the assets held in the Trust Account were held in a mutual fund. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of June 30, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, 36,426,674 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Offering Costs associated with the Initial Public Offering The Company complies with the requirements of ASC 340-10-S99-1 Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Derivative Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. re-assessed Derivative assets and liabilities are classified on the balance sheet as current or non-current net-cash Net Loss Per Ordinary Share Net loss per ordinary share is computed by dividing net loss by the weighted-average number of ordinary shares outstanding during the period. The Company has not considered the effect of the warrants sold in the IPO and the Private Placement since the exercise price of the warrants is in excess of the average ordinary share price for the period and therefore the inclusion of such warrants would be anti-dilutive. The warrants are exercisable to purchase 14,750,000 ordinary shares in the aggregate. The Company’s condensed statement of operations includes a presentation of income per share for Ordinary Shares subject to possible redemption in a manner similar to the two-class non-redeemable non-redeemable Non-redeemable Reconciliation of Net Loss per Ordinary Share The Company’s condensed statement of operations includes a presentation of loss per share for ordinary shares subject to redemption in a manner similar to the two-class For the three months ended For the period from January 13, Ordinary Shares Subject to Possible Redemption Numerator: Net income allocable to Ordinary Shares subject to possible redemption Interest earned on cash and investments held in trust $ 13,918 $ 15,362 Less: Franchise and income taxes — — Net income allocable to Ordinary Shares $ 13,918 $ 15,362 Denominator: Weighted Average Ordinary Shares subject to possible redemption Basic and diluted weighted average shares outstanding 39,550,000 39,221,649 Basic and diluted net income per share, Ordinary Shares subject to possible redemption $ 0.00 $ 0.00 Ordinary Shares Not Subject to Possible Redemption Numerator: Net loss minus redeemable net earnings Net loss $ (262,247 ) $ (994,586 ) Less: Income allocable to Ordinary Shares subject to possible redemption (13,918 ) (15,362 ) Adjusted Non-Redeemable $ (276,165 ) $ (1,009,948 ) Denominator: Weighted Average Ordinary Shares not subject to possible Redemption Basic and diluted weighted average shares outstanding not subject to possible redemption 9,887,500 9,805,412 Basic and diluted net loss per Ordinary Share $ (0.03 ) $ (0.10 ) Recently Adopted Accounting Standards In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) 815-40): 2020-06”), 2020-06 Management does not believe that any other recently issued, but not effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Initial Public Offering

Initial Public Offering	6 Months Ended
	Jun. 30, 2021
Equity [Abstract]
Initial Public Offering	Note 3 — Initial Public Offering Pursuant to the IPO on March 25, 2021, the Company sold 35,000,000 Units, at a price of $10.00 per Unit. On April 1 3 one-fifth

Private Placement

Private Placement	6 Months Ended
	Jun. 30, 2021
Private Placement [Abstract]
Private Placement	Note 4 — Private Placement Concurrently with the closing of the IPO, the Company completed the Private Placement of 6,000,000 Private Placement Warrants to Virgin Group Acquisition Sponsor II LLC at a purchase price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company of $9,000,000. On April 1 3

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Note 5 — Related Party Transactions Founder Shares On January 22, 2021 the Company issued 7,187,500 Class B Ordinary Shares to the Sponsor in consideration for the Sponsor paying certain offering and formation costs on behalf of the Company with a value of $25,000. On February 12, 2021, the Company effected a 33 35 3 , the IPO and exercise of the over-allotment option. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any Founder Shares until the earlier to occur of (i) one year after the completion of a Business Combination or (ii) the date following the completion of a Business Combination on which the Company completes a liquidation, merger, stock exchange or other similar transaction that results in all of the shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading Working Capital Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post- Business Combination entity at a price of $1.50 per warrant. Such warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of June 30, 2021, the Company had no outstanding borrowings under the Working Capital Loans. Administrative Service Fee Commencing on March 25, 2021, the Company has agreed to pay the Sponsor up to $10,000 per month for office space, secretarial and administrative services. Upon completion of the initial Business Combination or the Company’s need to disclose the three month period as well liquidation, it will cease paying these monthly fees. For the three month period from April 1, 2021 to June 30, 2021, the Company accrued of administrative service fees. For the period from January 13, 2021 (inception) to June 30, 2021, the Company has accrued of administrative service fees.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 6 — Fair Value Measurements The following table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of June 30, 2021, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments in the Mutual Fund. June 30, 2021 Quoted Prices In Active Markets (Level 1) Significant Other Significant Other (Level 3) Assets: Mutual Fund held in Trust Account $ 402,515,362 $ 402,515,362 $ — $ — Liabilities: Warrant liability – Public Warrants $ 10,338,960 $ 10,338,960 — — Warrant liability – Private Warrants 9,974,649 — 9,974,649 Warrant Liability $ 20,313,609 $ 10,338,960 $ — $ 9,974,649 The estimated fair value of the warrant liability for the private warrants at June 30, 2021 was determined using Level 3 inputs. Inherent in a Monte Carlo options pricing model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares based on projected volatility of comparable public companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement in May 2021 when the Public Warrants were listed separately. The following table provides quantitative information regarding Level 3 fair value measurements as of June 30, 2021: June 30, 2021 Strike price $ 11.50 Share price $ 9.31 Volatility 40.0 % Risk-free rate 1.07 % Expected term (years) 5.0

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 7 — Commitments and Contingencies Registration Rights The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement signed on March 22, 2021, the effective date of the IPO, requiring the Company to register such securities for resale. The holders of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriter a 45-day 3

Warrant Liability

Warrant Liability	6 Months Ended
	Jun. 30, 2021
Warrant Liability [Abstract]
Warrant Liability	Note 8 — Warrant Liability As of June 30, 2021, there were 8,050,000 Public Warrants and 6,700,000 Private Placement Warrants outstanding. The total Warrants will become exercisable on the later of (a) 30 days from the completion of a Business Combination or (b) 12 months from the closing of the IPO; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use its best efforts to file with the SEC and have an effective registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company’s Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, the Company will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The warrants will expire at 5:00 p.m., New York City time, five years after the completion of a Business Combination or earlier upon redemption or liquidation. On the exercise of any warrant, the warrant exercise price will be paid directly to the Company and not placed in the trust account. The Company may call the Public Warrants for redemption: • in whole and not in part; • at a price of $0.01 per warrant; • upon not less than 30 days’ prior written notice of redemption (the “30-day • if, and only if, the reported closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination, and (z) the volume weighted average trading price of the Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units being sold in the IPO, except that (x) the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (y) the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable The warrant agreement contains an Alternative Issuance provision that if less than 70% of the consideration receivable by the holders of the ordinary shares in the Business Combination is payable in the form of common equity in the successor entity, and if the holders of the warrants properly exercises the warrants within thirty days following the public disclosure of the consummation of Business Combination by the Company, the warrant price shall be reduced by an amount equal to the difference (but in no event less than zero) of (i) the warrant price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) minus (B) the Black-Scholes Warrant Value (as defined below). The “Black-Scholes Warrant Value” means the value of a Warrant immediately prior to the consummation of the Business Combination based on the Black-Scholes Warrant Model for a Capped American Call on Bloomberg Financial Markets. “Per Share Consideration” means (i) if the consideration paid to holders of the ordinary shares consists exclusively of cash, the amount of such cash per ordinary shares, and (ii) in all other cases, the volume weighted average price of the ordinary shares as reported during the ten-trading The Company believes that the Alternative Issuance provision and the adjustments to the exercise price of the warrants is based on a variable that is not an input to the fair value of a “fixed-for-fixed” The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon the closing of the IPO. Accordingly, the Company has classified each warrant as a liability at its fair value and the warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined by the Monte Carlo simulation. This liability is subject to re-measurement re-measurement, as of June 30, 2021 on the condensed unaudited balance sheet. The change in fair value of the warrant liabilities Warrant liability – initial Measurement $ 20,189,067 Change in fair 124,542 Warrant liabilities at June 30, 2021 $ 20,313,609

Shareholders' Equity

Shareholders' Equity	6 Months Ended
	Jun. 30, 2021
Equity [Abstract]
Shareholders' Equity	Note 9 — Shareholders’ Equity Preference Shares Class A Ordinary Shares Class B Ordinary Shares The Class B ordinary shares will automatically convert into Class A ordinary shares on with or immediately following the consummation of the initial Business Combination on a one-for-one sub-divisions, as-converted one-for-one

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 10 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The interim results for the three month period ending June 30, 2021 and for the period from January 13, 2021 (inception) through June 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s final prospectus filed by the Company with the SEC on March
Emerging Growth Company Status	Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Further, Section 102(b)(1) of the JOBS non-emerging
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, actual results could differ from those estimates. Estimates made in preparing these condensed financial statements include, among other things, the measurement of derivative warrant liabilities. Changes in these estimates and assumptions could have a significant impact on results in future periods.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021.
Investment in Trust Account	Investment in Trust Account At June 30, 2021, the assets held in the Trust Account were held in a mutual fund.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of June 30, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Ordinary Shares Subject to Possible Redemption	Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, 36,426,674 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.
Offering Costs associated with the Initial Public Offering	Offering Costs associated with the Initial Public Offering The Company complies with the requirements of ASC 340-10-S99-1
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Instruments	Derivative Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. re-assessed Derivative assets and liabilities are classified on the balance sheet as current or non-current net-cash
Net Loss Per Ordinary Share	Net Loss Per Ordinary Share Net loss per ordinary share is computed by dividing net loss by the weighted-average number of ordinary shares outstanding during the period. The Company has not considered the effect of the warrants sold in the IPO and the Private Placement since the exercise price of the warrants is in excess of the average ordinary share price for the period and therefore the inclusion of such warrants would be anti-dilutive. The warrants are exercisable to purchase 14,750,000 ordinary shares in the aggregate. The Company’s condensed statement of operations includes a presentation of income per share for Ordinary Shares subject to possible redemption in a manner similar to the two-class non-redeemable non-redeemable Non-redeemable Reconciliation of Net Loss per Ordinary Share The Company’s condensed statement of operations includes a presentation of loss per share for ordinary shares subject to redemption in a manner similar to the two-class For the three months ended For the period from January 13, Ordinary Shares Subject to Possible Redemption Numerator: Net income allocable to Ordinary Shares subject to possible redemption Interest earned on cash and investments held in trust $ 13,918 $ 15,362 Less: Franchise and income taxes — — Net income allocable to Ordinary Shares $ 13,918 $ 15,362 Denominator: Weighted Average Ordinary Shares subject to possible redemption Basic and diluted weighted average shares outstanding 39,550,000 39,221,649 Basic and diluted net income per share, Ordinary Shares subject to possible redemption $ 0.00 $ 0.00 Ordinary Shares Not Subject to Possible Redemption Numerator: Net loss minus redeemable net earnings Net loss $ (262,247 ) $ (994,586 ) Less: Income allocable to Ordinary Shares subject to possible redemption (13,918 ) (15,362 ) Adjusted Non-Redeemable $ (276,165 ) $ (1,009,948 ) Denominator: Weighted Average Ordinary Shares not subject to possible Redemption Basic and diluted weighted average shares outstanding not subject to possible redemption 9,887,500 9,805,412 Basic and diluted net loss per Ordinary Share $ (0.03 ) $ (0.10 )
Recently Adopted Accounting Standards	Recently Adopted Accounting Standards In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) 815-40): 2020-06”), 2020-06 Management does not believe that any other recently issued, but not effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Reconciliation Of Net Loss Per Ordinary Share	The Company’s condensed statement of operations includes a presentation of loss per share for ordinary shares subject to redemption in a manner similar to the two-class For the three months ended For the period from January 13, Ordinary Shares Subject to Possible Redemption Numerator: Net income allocable to Ordinary Shares subject to possible redemption Interest earned on cash and investments held in trust $ 13,918 $ 15,362 Less: Franchise and income taxes — — Net income allocable to Ordinary Shares $ 13,918 $ 15,362 Denominator: Weighted Average Ordinary Shares subject to possible redemption Basic and diluted weighted average shares outstanding 39,550,000 39,221,649 Basic and diluted net income per share, Ordinary Shares subject to possible redemption $ 0.00 $ 0.00 Ordinary Shares Not Subject to Possible Redemption Numerator: Net loss minus redeemable net earnings Net loss $ (262,247 ) $ (994,586 ) Less: Income allocable to Ordinary Shares subject to possible redemption (13,918 ) (15,362 ) Adjusted Non-Redeemable $ (276,165 ) $ (1,009,948 ) Denominator: Weighted Average Ordinary Shares not subject to possible Redemption Basic and diluted weighted average shares outstanding not subject to possible redemption 9,887,500 9,805,412 Basic and diluted net loss per Ordinary Share $ (0.03 ) $ (0.10 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2021
Fair Value Disclosures [Abstract]
Schedule Of Assets And Liabilities That Were Measured At Fair Value On A Recurring Basis	The following table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of June 30, 2021, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments in the Mutual Fund. June 30, 2021 Quoted Prices In Active Markets (Level 1) Significant Other Significant Other (Level 3) Assets: Mutual Fund held in Trust Account $ 402,515,362 $ 402,515,362 $ — $ — Liabilities: Warrant liability – Public Warrants $ 10,338,960 $ 10,338,960 — — Warrant liability – Private Warrants 9,974,649 — 9,974,649 Warrant Liability $ 20,313,609 $ 10,338,960 $ — $ 9,974,649
Schedule Of Quantitative Information Regarding Level 3 Fair Value Measurements	The following table provides quantitative information regarding Level 3 fair value measurements as of June 30, 2021: June 30, 2021 Strike price $ 11.50 Share price $ 9.31 Volatility 40.0 % Risk-free rate 1.07 % Expected term (years) 5.0

Warrant Liability (Tables)

Warrant Liability (Tables)	6 Months Ended
	Jun. 30, 2021
Warrant Liability [Abstract]
Schedule Of Change In Fair Value Of The Warrant Liabilities	The change in fair value of the warrant liabilities Warrant liability – initial Measurement $ 20,189,067 Change in fair 124,542 Warrant liabilities at June 30, 2021 $ 20,313,609

Organization and Business Ope_2

Organization and Business Operations - Additional Information (Detail) - USD ($)	Apr. 13, 2021	Mar. 25, 2021	Mar. 31, 2021	Jun. 30, 2021	Jan. 13, 2021
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Company incorporation date of incorporation				Jan. 13, 2021
Proceeds from initial public offering		$ 350,000,000
Total transaction costs incurred in connection with initial public offering				$ 19,845,525
Underwriting discount				7,000,000
Deferred underwriting discount non current				14,087,500
Deferred underwriting discount non current				12,250,000
Other offering costs				595,525
Proceeds from gross proceeds				9,000,000
Cash				$ 118,875
Term of restricted investments				180 days
Per share value of restricted asset				$ 10
Percentage of public shares to be redeemed in case business combination is not consummated				100.00%
Period within which business combination shall be consummated from the consummation of initial public offer				12 months
Temporary equity redemption price per share				$ 10
Minimum net worth to consummate business combination				$ 5,000,001
Percentage of public shares that can be transferred without any restriction				15.00%
Number of days within which public shares shall be redeemed				10 days
Expenses payable on dissolution				$ 100,000
Net working capital				$ 1,200,000
Private Placement Warrants
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Class of warrants or rights exercise price per share					$ 11.50
Proceeds from gross proceeds	$ 1,050,000
Class of warrants or rights warrants issued during the period units	700,000			6,000,000
Class of warrants or rights warrants issued issue price per warrant					$ 1.50
Minimum
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Prospective assets of acquiree as a percentage of fair value of assets in the trust account				80.00%
Equity method investment ownership percentage				50.00%
IPO
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock issued during the period shares	40,250,000
Total transaction costs incurred in connection with initial public offering				$ 22,733,025
Over-Allotment Option
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Proceeds from initial public offering	$ 52,500,000
Deferred underwriting discount non current				1,837,500
Underwriting discount				1,050,000
Units issued during period shares new issues	5,250,000
Stock issuance costs				$ 2,887,500
Class A Ordinary Shares
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock issued during the period shares			35,000,000
Common stock par or stated value per share				$ 0.0001
Temporary equity redemption price per share				$ 10
Class A Ordinary Shares | IPO
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock issued during the period shares		35,000,000
Common stock par or stated value per share		$ 0.0001
Class of warrants or rights number of shares called by each warrant or right		1
Class of warrants or rights exercise price per share		$ 11.50
Sale of stock issue price per share		$ 10

Significant Accounting Polici_4

Significant Accounting Policies - Reconciliation Of Net Loss Per Ordinary Share (Detail) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2021
Numerator: Net income allocable to Ordinary Shares subject to possible redemption
Interest earned on cash and investments held in trust	$ 13,918		$ 15,362
Basic and diluted weighted average shares outstanding	9,887,500		9,805,412
Basic and diluted net income per share, Ordinary Shares subject to possible redemption	$ (0.03)		$ (0.10)
Basic and diluted weighted average shares outstanding not subject to possible redemption	9,887,500		9,805,412
Basic and diluted net loss per ordinary share	$ (0.03)		$ (0.10)
Numerator: Net loss minus redeemable net earnings
Adjusted Non-Redeemable Net loss	$ 262,247	$ 732,339	$ 994,586
Class A Common Stock Subject To Possible Redemption
Numerator: Net income allocable to Ordinary Shares subject to possible redemption
Interest earned on cash and investments held in trust	13,918		15,362
Less: Franchise and income taxes			0
Net income allocable to Ordinary Shares	$ 13,918		$ 15,362
Basic and diluted weighted average shares outstanding	39,550,000		39,221,649
Basic and diluted net income per share, Ordinary Shares subject to possible redemption	$ 0		$ 0
Basic and diluted weighted average shares outstanding not subject to possible redemption	39,550,000		39,221,649
Basic and diluted net loss per ordinary share	$ 0		$ 0
Numerator: Net loss minus redeemable net earnings
Less: Income allocable to Ordinary Shares subject to possible redemption	$ (13,918)		$ (15,362)
Common Class B
Numerator: Net income allocable to Ordinary Shares subject to possible redemption
Net income allocable to Ordinary Shares	$ 13,918		$ 15,362
Basic and diluted weighted average shares outstanding	9,887,500		9,805,412
Basic and diluted net income per share, Ordinary Shares subject to possible redemption	$ (0.03)		$ (0.10)
Basic and diluted weighted average shares outstanding not subject to possible redemption	9,887,500		9,805,412
Basic and diluted net loss per ordinary share	$ (0.03)		$ (0.10)
Numerator: Net loss minus redeemable net earnings
Net loss	$ (262,247)		$ (994,586)
Less: Income allocable to Ordinary Shares subject to possible redemption	(13,918)		(15,362)
Adjusted Non-Redeemable Net loss	$ (276,165)		$ (1,009,948)

Significant Accounting Polici_5

Significant Accounting Policies - Additional Information (Detail) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2021
Accounting Policies [Line Items]
Cash	$ 0		$ 0
Total transaction costs incurred in connection with initial public offering			19,845,525
Adjustment to additional paid in capital stock issuance costs	$ 1,764,638	$ 19,347,891
Offering costs allocated to warrant liability			570,496
IPO
Accounting Policies [Line Items]
Total transaction costs incurred in connection with initial public offering			22,733,025
Adjustment to additional paid in capital stock issuance costs			$ 22,162,529
Private Placement Warrants
Accounting Policies [Line Items]
Class of warrants or rights number of shares called by the warrants or rights	14,750,000		14,750,000
Minimum
Accounting Policies [Line Items]
Cash insured with federal depository insurance corporation	$ 250,000		$ 250,000
Class A Common Stock Subject To Possible Redemption
Accounting Policies [Line Items]
Temporary equity shares outstanding	36,426,674		36,426,674

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Detail) - $ / shares	Apr. 13, 2021	Mar. 25, 2021	Jun. 30, 2021	Mar. 31, 2021
IPO
Class of Stock [Line Items]
Stock issued during the period shares	40,250,000
Over-Allotment Option
Class of Stock [Line Items]
Units issued during period shares new issues	5,250,000
Class A Ordinary Shares
Class of Stock [Line Items]
Stock issued during the period shares				35,000,000
Common stock par or stated value per share			$ 0.0001
Units issued during period shares new issues			5,250,000
Class A Ordinary Shares | IPO
Class of Stock [Line Items]
Stock issued during the period shares		35,000,000
Common stock par or stated value per share		$ 0.0001
Class of warrants or rights number of shares called by each warrant or right		1
Class of warrants or rights exercise price per share		$ 11.50
Sale of stock issue price per share		$ 10

Private Placement - Additional

Private Placement - Additional Information (Detail) - USD ($)	Apr. 13, 2021	Jun. 30, 2021	Jan. 13, 2021
Private Placement [Line Items]
Payment to acquire restricted investments		$ 402,500,000
Proceeds from issuance of warrants	$ 10,050,000	$ 9,000,000
Private Placement Warrants
Private Placement [Line Items]
Class of warrants or rights warrants issued during the period units	700,000	6,000,000
Class of warrants or rights warrants issued issue price per warrant			$ 1.50
Class of warrants or rights exercise price per share			$ 11.50
Private Placement Warrants | Sponsor
Private Placement [Line Items]
Class of warrants or rights warrants issued during the period units		6,700,000
Proceeds from issuance of warrants	$ 1,050,000

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail)	Mar. 22, 2021shares	Feb. 12, 2021shares	Jan. 22, 2021USD ($)shares	Jun. 30, 2021USD ($)$ / sharesshares	Mar. 31, 2021USD ($)shares	Jun. 30, 2021USD ($)$ / sharesshares	Apr. 13, 2021shares
Related Party Transaction [Line Items]
Stock shares issued during the period for services value					$ 25,000
Over-Allotment Option [Member]
Related Party Transaction [Line Items]
Common Stock, Shares, Subject to Forfeiture | shares							1,312,500
Sponsor | Administration And Support Services
Related Party Transaction [Line Items]
Related party transaction fees payable per month				$ 10,000		$ 10,000
Due to related party current				30,000		30,000
Sponsor | Administration And Support Services | General and Administrative Expense
Related Party Transaction [Line Items]
Related party transaction administration expenses incurred				31,667		30,000
Sponsor | Working Capital Loans
Related Party Transaction [Line Items]
Working capital loans convertible into equity warrants				$ 1,500,000		$ 1,500,000
Debt instrument conversion price per share | $ / shares				$ 1.50		$ 1.50
Bank overdrafts				$ 0		$ 0
Common Class B
Related Party Transaction [Line Items]
Stock shares issued during the period for services shares | shares					10,062,500
Stock shares issued during the period for services value					$ 1,006
Common stock shares outstanding | shares				10,062,500		10,062,500
Common Class B | Founder
Related Party Transaction [Line Items]
Stock shares issued during the period for services shares | shares			7,187,500
Stock shares issued during the period for services value			$ 25,000
Stock split ratio	1.0606	1.32
Common stock shares outstanding | shares	10,062,500	9,487,500
Percentage of common stock issued and outstanding				20.00%		20.00%
Common Class B | Sponsor | Restriction On Transfer Of Sponsor Shares
Related Party Transaction [Line Items]
Lock in period of shares						1 year
Share Price | $ / shares				$ 12		$ 12
Waiting period after which the share trading days are considered						150 days
Number of trading days for determining share price						20 days
Number of consecutive trading days for determining the share price						30 days

Fair Value Measurements - Sched

Fair Value Measurements - Schedule Of Assets And Liabilities That Were Measured At Fair Value On A Recurring Basis (Detail) - USD ($)	Jun. 30, 2021	Mar. 25, 2021	Jan. 12, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mutual Fund held in Trust Account	$ 402,515,362
Warrant liability	20,313,609		$ 20,189,067
Public Warrants | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	10,338,960
Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability		$ 20,189,067
Private Placement Warrants | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	20,313,609	$ 17,796,406
Mutual Fund | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mutual Fund held in Trust Account	402,515,362
Mutual Fund | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mutual Fund held in Trust Account	402,515,362
Warrant | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	20,313,609
Warrant | Fair Value, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	10,338,960
Warrant | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	9,974,649
Warrant | Public Warrants | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	10,338,960
Warrant | Private Placement Warrants | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	9,974,649
Warrant | Private Placement Warrants | Fair Value, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	$ 9,974,649

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule Of Quantitative Information Regarding Level 3 Fair Value Measurements (Detail) - Levels 3 [Member]	6 Months Ended
	Jun. 30, 2021$ / shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Strike price	$ 11.50
Share Price	$ 9.31
Volatility	40.00%
Risk-free rate	1.07%
Expected term (years)	5 years

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($)	Apr. 13, 2021	Jun. 30, 2021
Other Commitments [Line Items]
Deferred underwriting commission		$ 14,087,500
Over-Allotment Option
Other Commitments [Line Items]
Deferred underwriting commission		$ 1,837,500
Underwriting Agreement | Over-Allotment Option
Other Commitments [Line Items]
Common stock shares subscribed but not issued		5,250,000
Underwriting discount per share	$ 0.20
Payment of underwriting discount	$ 8,050,000
Deferred underwriting discount per share	$ 0.35
Deferred underwriting commission	$ 14,087,500	$ 14,087,500
Stock shares issued during the period shares	5,250,000

Warrant Liability - Additional

Warrant Liability - Additional Information (Detail) - USD ($)	Jun. 30, 2021	Jun. 30, 2021	Mar. 25, 2021	Jan. 12, 2021
Warrant Liability [Line Items]
Number of days after consummation of business combination within which the securities shall be registered	15 days
Number of days after which business combination within which securities registration shall be effective	60 days
Percentage of consideration payable to shareholders of predecessor company in shares	70.00%	70.00%
Financial liabilities at fair value	$ 20,313,609	$ 20,313,609		$ 20,189,067
Changes in fair value of financial liabilities recorded in earnings		$ 124,542
Levels 3 [Member]
Warrant Liability [Line Items]
Share price	$ 9.31	$ 9.31
Private Placement Warrants
Warrant Liability [Line Items]
Class of warrants or rights outstanding	6,700,000	6,700,000
Warrants and rights outstanding term	5 years	5 years
Class of warrants or rights lock in period	30 days
Financial liabilities at fair value			$ 20,189,067
Private Placement Warrants | Over-Allotment Option
Warrant Liability [Line Items]
Financial liabilities at fair value			2,392,661
Private Placement Warrants | Levels 3 [Member]
Warrant Liability [Line Items]
Financial liabilities at fair value	$ 20,313,609	$ 20,313,609	$ 17,796,406
Changes in fair value of financial liabilities recorded in earnings	$ 124,542
Public Warrants
Warrant Liability [Line Items]
Class of warrants or rights outstanding	8,050,000	8,050,000
Warrants and rights outstanding term	5 years	5 years
Class of warrants or rights redemption price per unit	$ 0.01	$ 0.01
Minimum notice period to be given to the holders of warrants		30 days
Public Warrants | Class A ordinary shares
Warrant Liability [Line Items]
Share price	$ 18	$ 18
Number of trading days for determining the share price		20 days
Number of consecutive trading days for determining the share price		30 days
Proceeds from equity used for funding business combination as a percentage of the total		60.00%
Number of consecutive trading days for determining volume weighted average price of shares	20 days
Public Warrants | Class A ordinary shares | Adjusted Exercise Price Two
Warrant Liability [Line Items]
Adjusted exercise price of warrants as a percentage of newly issued price	115.00%	115.00%
Public Warrants | Class A ordinary shares | Adjusted Exercise Price One
Warrant Liability [Line Items]
Adjusted exercise price of warrants as a percentage of newly issued price	180.00%	180.00%
Public Warrants | Class A ordinary shares | Minimum
Warrant Liability [Line Items]
Volume weighted average price of shares	$ 9.20
From The Completion Of Business Combination | Public Warrants
Warrant Liability [Line Items]
Period after which the warrants are exercisable	30 days
From The Completion Of Initial Public Offer | Private Placement Warrants
Warrant Liability [Line Items]
Period after which the warrants are exercisable	12 months

Warrant Liability - Schedule Of

Warrant Liability - Schedule Of Change In Fair Value Of The Warrant Liabilities (Detail)	6 Months Ended
	Jun. 30, 2021USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Warrant liability – initial Measurement	$ 20,189,067
Change in fair value of warrant liabilities	124,542
Warrant liability, ending balance	$ 20,313,609

Shareholders' Equity - Addition

Shareholders' Equity - Additional Information (Detail) - $ / shares	Jun. 30, 2021	Mar. 22, 2021	Feb. 12, 2021
Class of Stock [Line Items]
Preferred stock, shares authorized	1,000,000
Preferred stock, par value	$ 0.0001
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0
Class A Ordinary Shares
Class of Stock [Line Items]
Common stock, shares authorized	200,000,000
Common stock, par value	$ 0.0001
Common stock, shares issued	3,823,326
Common stock, shares outstanding	3,823,326
Class A Ordinary Shares | Common Stock
Class of Stock [Line Items]
Common stock, shares authorized	200,000,000
Common stock, par value	$ 0.0001
Common stock, shares issued	3,823,326
Common stock, shares outstanding	3,823,326
Temporary equity shares outstanding	36,426,674
Class A Ordinary Shares | Founder
Class of Stock [Line Items]
Percentage of common stock issued and outstanding	20.00%
Class B Ordinary Shares
Class of Stock [Line Items]
Common stock, shares authorized	20,000,000
Common stock, par value	$ 0.0001
Common stock, shares issued	10,062,500
Common stock, shares outstanding	10,062,500
Percentage holding of common stock eligible for voting of directors	50.00%
Percentage votes in terms of stock holding to approve voting rights of shares of another class	90.00%
Class B Ordinary Shares | Common Stock
Class of Stock [Line Items]
Common stock, shares authorized	20,000,000
Common stock, par value	$ 0.0001
Common stock, shares issued	10,062,000
Common stock, shares outstanding	10,062,000
Class B Ordinary Shares | Founder
Class of Stock [Line Items]
Common stock, shares outstanding		10,062,500	9,487,500
Percentage of common stock issued and outstanding	20.00%